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Abstract
A broken DNA molecule is difficult to repair, highly mutagenic, and extremely cytotoxic. Such breaks can be repaired by
homology-independent or homology-directed mechanisms. Little is known about the network that controls the repair
pathway choice except that a licensing step for homology-mediated repair exists, called DNA-end resection. The choice
between these two repair pathways is a key event for genomic stability maintenance, and an imbalance of the ratio is
directly linked with human diseases, including cancer. Here we present novel reporters to study the balance between both
repair options in human cells. In these systems, a double-strand break can be alternatively repaired by homology-
independent or -dependent mechanisms, leading to the accumulation of distinct fluorescent proteins. These reporters thus
allow the balance between both repair pathways to be analyzed in different experimental setups. We validated the
reporters by analyzing the effect of protein downregulation of the DNA end resection and non-homologous end-joining
pathways. Finally, we analyzed the role of the DNA damage response on double-strand break (DSB) repair mechanism
selection. Our reporters could be used in the future to understand the roles of specific factors, whole pathways, or drugs in
DSB repair pathway choice, or for genome-wide screening. Moreover, our findings can be applied to increase gene-
targeting efficiency, making it a beneficial tool for a broad audience in the biological sciences.
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Introduction
DNA is under the constant attack of many agents, physical and
chemical, that alter its structure [1,2]. Although those alterations
are usually repaired, genomes are never completely stable [3].
This low level of genomic instability does not compromise cell or
organismal survival and is the main force driving evolution [3].
However, if the cellular DNA repair pathways are mutated,
genomes become increasingly unstable, a phenomena tightly
related to several human pathologies, including cancer [1–3].
There are many types of DNA damage and, correspondingly,
many DNA repair pathways [1,2]. Many of these take advantage
of the double-stranded nature of DNA to use an intact strand to
recover the information lost in the damaged strand. This is not
possible when a break occurs simultaneously on both strands, a so-
called double-strand break (DSB). As a consequence, DSB DNA
lesions are extremely difficult to repair and are highly cytotoxic
and mutagenic [1–8]. While there are several cellular pathways
that repair DSBs [4,9], all can be grouped into one of two
categories: homology-independent (non-homologous end joining;
NHEJ) [6] or homology-mediated repair [8]. While the former
mechanistically consists of a simple ligation of two ends, the latter
is more complex and requires that a homologous sequence is used
as a template for repair. There are various NHEJ repair pathways.
The majority of NHEJ repairs use the classical NHEJ repair
pathway, which is mediated by the DNA-PKcs-Ku70–Ku80
complex and ligase 4 [6]. However, in some circumstances DSBs
are repaired by a Ku-independent repair mechanism that use
microhomology as an intermediate and is dependent on ligase 3
[10,11]; this is termed Alt-NHEJ. Similarly, there are four different
homology-mediated mechanisms: the three core homologous
recombination subpathways (double Holliday junction, synthesis-
dependent strand annealing, and break-induced replication) and
the intramolecular mechanism single-strand annealing (SSA) [9].
All of these mechanisms use a homologous molecule during the
repair process, but whereas the first three require Rad51-mediated
DNA invasion of the homologous partner, SSA is Rad51
independent. However, all of these are initiated by the same
mechanism, a licensing step known as DNA-end resection [5].
Therefore, despite the different mechanisms and outcomes of these
pathways, all can be grouped and analyzed as a single category of
homology-mediated repair (HR).
DNA-end resection in human cells is controlled by the action of
several proteins [5]. First, the MRN complex (Mre11-Rad50-
Nbs1) recognizes the break [5]. If the break will be repaired by
HR, the coordinated action of the MRN complex and CtIP
protein activates a 59-to-39 nucleolytic degradation of both ends,
close to the break (short-range resection) [5]. In a second wave
(termed long-range resection), the exonuclease Exo1 and/or the
helicase BLM act together with an unknown nuclease in higher
eukaryotes (budding yeast BLM homologue Sgs1 acts with the
nuclease Dna2), to extend the resected DNA by several kilobases
[5]. Resected DNA is an essential intermediate of all homology-
mediated repair pathways and also inhibits classical NHEJ due to
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the inability of core NHEJ proteins to bind single-stranded DNA
(ssDNA) [12]. As in homology-mediated repair, Alt-NHEJ
requires resected DNA to expose the microhomologies used
during repair. Hence, the Alt-NHEJ pathway mechanistically
shares steps with both HR and classical NHEJ.
Appropriate DSB repair is essential for cellular and organismal
survival. In humans, many diseases are related to mutations in
DSB repair protein-coding genes [2,7]. However, in many cases
these conditions are not caused by a specific impairment in one
type of repair, but by an imbalance between homology-driven
versus homology-independent repair mechanisms [9,13]. Whereas
our knowledge of the mechanisms of repair is quite extensive, how
the decision between NHEJ and HR is made is still unknown.
Here, we present two different systems that we specifically
designed to tackle this question. We created a construct in which
the formation of DSBs can be induced using the meganuclease I-
SceI. In contrast to previously reported systems, which can
measure either classical NHEJ or specific HR subtypes, our
reporters allow us to monitor the ratio between homology-driven
and homology-independent repair by emitting the distinct
fluorescent signals of red for HR and green for NHEJ. We
validated these reporter systems by manipulating either NHEJ or
DNA-end resection. Finally, we analyzed the effect of downreg-
ulating different DNA damage checkpoint proteins on the balance
between these repair pathways.
Materials and Methods
Cloning of SSR Systems
Both SSRs (Figure 1A and 1B) were derived from the pEGFP-
C1 plasmid. For nuclease-cleavage-sequence cloning, two an-
nealed oligonucleotides bearing either one (SSR 1.0; 59-AATT-
CAGTTACGCTAGGGATAACAGGGTAATATAGtaaaatC-
TATATTACCCTGTTATCCCTAGCGTAACT-39) or two
(SSR 2.0; 59-AATTCACTAGGGGATAACAGGGTAATAA-
TAATTACCCTGTTATCCCTATG-39 and 59-AATTCA-
TAGGGATAACAGGGTAATTATTATTACCCTGT-
TATCCCTAGTG-39) inverted I-SceI target sequences were
inserted at the 39 end of the GFP gene. Both RFP repeats were
obtained from the Hc-Red plasmid by PCR. An AgeI-AgeI
fragment harboring the 59 end of the gene (RF) was obtained
using the oligonucleotides 59-ATGTCGTAACAACTCCGCC-39
and 59-GGACTTACCGGTCCGCTCTTGTTCTTCATC-39
and cloned at an AgeI restriction site located between the CMV
promoter and the GFP gene, maintaining the reading frame. A
SalI-BamHI PCR product bearing the 39 end of the RFP gene (FP)
was obtained using the oligonucleotides 59-GGACTTGTCGA-
CACCCAGAGCATGAGAATCCAC-39 and 59-GTCGACG-
GATCCTGCAGAATTCGAAGCTTGAGCTCGAGA-39 and
cloned at SalI and BamHI sites, just behind the I-SceI site(s). The
RF and FP fragments share 302 bp of homology (Figure 1A and
1B). The original SSR 1.0 reporter showed low GFP expression.
To boost it, we inserted a PCR fragment containing the
woodchuck hepatitis post-transcriptional regulatory element
(WPRE) at KpnI-SalI restriction site to stabilize the mRNA.
Cell Culture and Drug Treatments
Both SSR reporters were integrated in U2OS osteosarcoma
cells (ATCC #HTB-96) by plasmid transfection using Fugene6
Transfection Reagent (Roche) according to the manufacturers
instructions. Cells were cultured in high-glucose Dulbecco’s
Modified Eagle Medium (DMEM) supplemented with 10% FBS,
2 mM Glutamine, 100 mg/ml streptomycin, 100 U/ml penicillin,
and 0.5 mg/ml G418 at 37uC in 5% CO2. U2OS stably
expressing SSR systems were selected with 0.5 mg/ml G418
antibiotics. Single clones of both reporter systems were obtained
by plating 1000 cells in 15 cm diameter plates and selection of
isolated colonies.
Southern Blot
Southern blot analyses were performed according to standard
procedures with 32P-radiolabelled probes. The DNA probe of a
GFP fragment obtained by PCR amplification (using the primers
59-CACGAACTCCAGCAGGACCATG-39 and 59-
CTGGTCGAGCTGGACGGCGACG-39) was labeled with 32P.
The product was labeled with 500 mg/ml N6 random primers,
0.03 mM each of dATP, dGTP, and dTTP, 0.01 dCTP, 1 mCi/
ml [32P]dCTP, and Klenow polymerase during 2 hr at 37uC. The
labeled product was purified with G25 columns (Amersham,
NAP5). To obtain the DNA cells were growth in 10 cm plates to
confluence, collected by trypsinization, and resuspended in 300 ml
of lysis buffer (50 mM Tris pH 7.5, 100 mM NaCl, 0.5% SDS,
and 5 mM EDTA) with 20 mg/ml proteinase K, and incubated
overnight at 55uC with agitation. DNA was precipitated with 1
volume of isopropanol and centrifuged at 13000 g. The DNA
pellet was washed with 70% ethanol and resuspended in 40 ml
H2O. DNA (40 mg) was digested with EcoRI overnight at 37uC,
resolved on a 0.8% agarose gel, and transferred to a Hybond
N+membrane (Amersham) by capillarity blotting. The membrane
was hybridized with the GFP-labeled fragment in hybridization
buffer (0.25 M Na2HPO4, 0.2% H3PO4, 7% SDS, and 1 mM
EDTA) overnight at 65uC, washed three times at 50uC with
washing buffer (0.1% SSC, 1% SDS), and quantified in a FUJI
FLA5000.
Genomic DNA PCR
Genomic DNA was extracted from U2OS cells stably trans-
fected with the SSR2.0 system, as indicated in the Southern blot
section. Samples were collected 24, 48, and 72 hr after I-SceI
lentiviral transduction. PCR was performed using primers flanking
the I-SceI target site (Fw 59-CACGAACTCCAGCAGGAC-
CATG-39 and Rv 59-ATGTTTCAGGTTCAGGGGGAGG-39)
or inside the actin gene for 30 amplification cycles. PCR products
were resolved in 4% native acrylamide/bisacrylamide gel (I-SceI
target site) or 1.5% agarose (actin PCR), stained with RedSafe
(Intron Biotechnology, ref 21141) for 10 min, visualized with UV
light, and documented using a Gel-Doc XR+System (BioRad).
The resultant image was quantified using the Quantity One
software (BioRad). The ratio between the density of the band from
the reporter and the one from the actin gene was normalized to
the time 0 (e.g. before I-SceI infection).
Lentiviral Production and Infection
Lentiviral particles harboring the I-SceI gene were generated
using 10 mg p8.91, 5 mg pVSV-G, and 15 mg pRRL_sEF1a_-
HA.NLS.SceOPT.T2A.TagBFP vectors (Andrew Scharenberg) by
calcium phosphate transfection in A293T cells. After 48 hr,
lentiviruses were collected from the media by 100,000 g centri-
fugation for 2 hr at 4uC. The virus titer was calculated by infecting
U2OS cells with fixed amounts of the virus suspension and
analyzing the percentage of BFP-expressing cells by FACS.
Lentiviral particles bearing short hairpin RNA (shRNA) against
different messenger RNAs (see Table S1 for the list and access
numbers) were obtained from Sigma Aldrich. Infection was
performed according the manufacturers manual. U2OS cells
stably expressing the shRNAs were selected by adding 1 mg/ml
puromycin to the medium after infection.
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Flow Cytometry
Inhibitor-treated or shRNA-depleted samples were prepared for
FACS analysis as following. Cells were seeded in 12-well plate
(50,000 cells per well) in duplicate. The next day, cells were
infected with lentivirus particles containing I-SceI–BFP expression
construct at MOI 5 using 8 mg/ml polybrene in 300 ml DMEM.
After 6 hr, media was exchanged with fresh DMEM. For
inhibitor-treated samples, drugs or, as a control, the vehicle
DMSO was added at this point. After 16–18 hr, cells were washed
with PBS, trypsinized, neutralized in DMEM, and centrifugated at
800 g. Cells were resuspended, fixed with 4% paraformaldehyde
for 20 min, and collected by centrifugation. Pellets were then
washed twice with PBS and resuspended in 200 ml PBS. Samples
were analyzed with a BD FACSAria with the BD FACSDiva
Software v5.0.3. Five different parameters were considered: side
scatter (SSC), forward scatter (FSC), blue fluorescence (407 nm
violet laser BP, Filter 450/40), green fluorescence (488 nm blue
laser BP Filter 530/30), and red fluorescence (488 nm blue laser
BP Filter 575/26). The number of green and red cells from 10,000
events positives for blue fluorescence (infected with the I-SceI–BFP
construct) was measured. The average of both duplicates was
calculated for each experiment. At least two completely indepen-
dent experiments were carried out for each condition.
Microscopy
About 4000 U2OS cells stably transfected with the SSR system
bearing different shRNAs were seeded. I-SceI-BFP Lentiviral
transduction were performed using an MOI 5, changing the media
after 24 hr. Cells were grown during 48 hr, fixed with 4%
paraformaldehyde, and washed with PBS prior visualization with a
fluorescent microscope.
Homology-dependent and Homology-independent Ratio
Quantification
The HR/NHEJ ratio was calculated by dividing the number of
cells expressing GFP from the subpopulations expressing BFP by
the number of cells expressing RFP from the subpopulations
expressing BFP. To avoid noise due to the random events that
create RFP-expressing cells prior to I-SceI induction, a parallel
experiment without I-SceI infection was performed for each
shRNA-infected cell line and used as background. The HR/NHEJ
ratio was normalized to the cells expressing the shRNA control.
Results and Discussion
A Novel Set of Reporters to Study the Balance between
Homology Dependent and Independent Repair
As DNA resection dictates the way a DSB is going to be
repaired [5,9], we have designed a resection-sensitive set of
reporters to measure the balance between NHEJ and HR. The
goal was to detect changes in the ratio between repair pathways,
irrespective if they were caused by increase and/or decrease of HR
or NHEJ. We called this constructs the SeeSaw Reporters (SSR),
as a deviation towards any directions does not depend on one
repair mechanism but rather on the combination of both. Hence,
a net bias towards HR or NHEJ in our reporters does not
necessarily reflect an increase or decrease of either one but rather
an imbalance between both (Figure 1).
The SSR consists of the GFP gene flanked by a 39- and a 59-end
truncated portion of the RFP gene that share 302 bp of homology
with each other (Figure 1a and 1b). The sequence recognized by
the meganuclease I-SceI was inserted at the 39 end of the GFP
gene. It is worth noting that the reporters were designed to express
the GFP gene constitutively. We decided to use this approach
rather than the conventional approach, which is to place the I-SceI
at the beginning of the gene and disrupt the reading frame, so that
cells with the reporters do not express any fluorescent signal prior
to repair. Our rationale was that the conventional way would
allow us to observe only those NHEJ events in which mutagenic
repair restored the reading frame. In other words, conventional
reporters do not detect classical error-free NHEJ or the majority of
mutagenic end-joining (e.g. those events that do not restore the
appropriate reading frame). In contrast, our reporters allow us to
observe both error-free and error-prone NHEJ.
We designed two different reporters: SSR 1.0 with a single I-
SceI target site (Figure 1A) and SSR 2.0 with two I-SceI target site
(Figure 1B). In the single-site reporter, I-SceI cleavage generates
Figure 1. Graphical representation and experimental validation of the HRNH1.0 reporter. Schematic representation of the SeeSaw
reporter (SSR) 1.0 (A) and SSR 2.0 (B). A GFP gene is flanked by two truncated parts of the RFP gene (RF and FP) that share 302 bp of homologous
sequence. One I-SceI target site in SSR 1.0 (A), and two in opposite orientation in SSR 2.0 (B), were cloned at the 39 end of the GFP gene. Expression of
I-SceI generates a DSB; if the damage is resolved by NHEJ, cells will express the GFP protein, while if it is repaired using homologous sequence by HR,
cells express the RFP gene. The PCR products used in Figure 2F are depicted as ‘‘uncut PCR fragment’’ and ‘‘cut and repaired PCR fragment’’.
doi:10.1371/journal.pone.0077206.g001
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ligatable, 39-overhanging ends that can be joined accurately by
NHEJ to re-create the I-SceI target site, which can in turn be cut
again by the enzyme. This cycle can be repeated endlessly until the
I-SceI site disappears either by homology-mediated repair or
mutagenic end-joining. Thus, one caveat this system shares with
previously published reporters is that it is biased to mutagenic
repair. To study the extent of this bias in our reporter, we
generated the version with two I-SceI sites, which are close to each
other in an inverted orientation (Figure 1B). The I-SceI target site
is not palindromic, and hence the repair of two inverted I-SceI–
mediated breaks by NHEJ always destroys the target sequence and
the intervening sequence if they occur simultaneously. Indeed,
when we analyzed the break repair of SSR 2.0 by PCR, we only
observed the cut-and-repair band corresponding to a double-
cleavage event (Figure 2F). Thus, in this new See-Saw Reporter
2.0, both NHEJ and HR destroy the I-SceI site, and the majority
of the repair events represent a single cycle of breakage-repair.
Infection with a lentivirus harboring the I-SceI gene creates
DSBs. When cells repair such breaks through a classical NHEJ-
type of repair, the GFP gene is restored and the cells fluoresce
green (Figure 1A, 1B, 2A–2E). When resection takes place, thereby
inhibiting classical NHEJ, the homologous regions of the RFP gene
are exposed and used to repair the break by SSA [5,8,9]. In this
case, the repair creates a functional RFP gene and eliminates the
GFP gene, and the cells fluoresce red (Figure 1A, 1B, 2A–2E). One
additional possibility is that resection takes place but the repair is
mediated by alt-NHEJ. In this case, cells might lose the
intervening region, e.g. the GFP gene, without creating a
functional RFP gene [4,9,10]. In this case, cells would fluoresce
neither green nor red and should thus be invisible in our system.
Unfortunately, in all our stably transfected cells, there were always
a significant percentage of cells that fit this condition (see tables
S2–S7). We reasoned that these cells represent an heterogenous
population formed by: i) cells that have not yet repaired the break,
or that have repaired it too recently for the fluorescent protein to
accumulate to large enough levels to be visualized by FACS; ii)
cells that maintain resistance but have lost the reporter and thus
express neither GFP nor RFP; or iii) cells that have repaired the
break in a way that hamper both RFP and GFP expression, such as
alt-NHEJ.
One possible caveat of this approach is that those cells in which
I-SceI is not present will remain green, affecting the measurement
of NHEJ events. To analyze only cells that were infected with I-
SceI, and therefore in which a DSB had been induced, we used a
blue-fluorescent protein (BFP)–I-SceI construct (Figure 2B) and
restricted the analysis to those cells that fluoresce blue. Also, cells
in which I-SceI was present but in which the DNA had not been
cleaved continued to express GFP. However, as can be seen in
Figure 2F for SSR 2.0, the percentage of cells in which this
happened was negligible: 24 hr after infection, 40% of the cells
with the reporter were uncut, while after 48 hr, less than 1% of the
report was uncut. In addition, at 48 hr, a smaller band
corresponding to the joined molecule that had lost one copy of
the I-SceI site as well as the intervening sequence began to
accumulate (Figure 2F). It can be argued that any GFP protein
produced before I-SceI cleavage would still be present in the cells.
However, if this were true, RFP-positive cells would also be
positive for GFP expression, at least in some cases. As can be seen
in Figure 2E, we never observed such cells, implying that GFP
expression measured in our reporters corresponded to GFP that
was expressed after DNA repair had occurred.
Therefore, these reporters allow us to analyze the balance
between homology-dependent and -independent repair by deter-
mining the percentage of green versus red cells in the population
by FACS (Figures 2A–2D) or microscopy (Figure 2E). We decided
to use a SSA reporter as an indicator of homology-mediated
repair, rather than a classical recombination reporter, mainly due
to its increased efficiency. Rad51-mediated recombination is a rare
event, and we reasoned that it would be difficult to observe
changes when compared with NHEJ. To analyze the effects of
different cellular processes in the balance between DSB repair
pathways, we stably integrated the reporter into U2OS cells. For
our studies, we used clones that harbored single-copy integration
of the reporters (Figure S1).
In a population of U2OS cells stably transfected with the SSR
reporters, we observed cells that expressed green fluorescence
above background levels even without I-SceI transfection (com-
pare U2OS with U2OS-SSR 1.0 cells) Figure 2A; region 2, R2)
These depicts cells with the SSR that constitutively expressed
GFP. We also observed a low number of cells (less than 1%) that
emitted red fluorescence (Figure 2A; region 1, R1), which we
interpreted to be spontaneous SSA events that were not triggered
by I-SceI cleavage. As mentioned above, we only analyzed cells
that harbored the I-SceI-BFP construct (Figure 1D). Two days
after I-SceI infection, we prepare the cells as described in the
Methods section and analyzed them by FACS (Figure 2B and 2C)
or microscopy (Figure 2E) for blue, green, and red fluorescence.
Continuous expression of I-SceI for two days led to almost 100%
cleavage of the reporter (Figure 2F). To calculate the balance
between HR and NHEJ, we considered the cells that expressed the
I-SceI–BFP construct (Figure 2B, gate 1). Those cells that fall into
Gate1 are then analyzed for the appearance of red (in R1) or green
fluorescence (in R2) (Figure 2C). We calculated the ratio between
homology-mediated versus homology-independent repair (R1/R2)
(Figure 2D). Similar results were obtained with the SSR 1.0 and
SSR 2.0 reporters, indicating that repair balance is not strongly
biased in any of the systems (Figure 2D) in control cells. We
observed that for both reporters, and as measured both by FACS
or microscopy, cells showed a 4:6 ratio of HR compared to NHEJ;
i.e., 40% of the cells repair using the homologous sequence.
Although this proportion might seem high for homology-mediated
repair, it is worth pointing out that SSA is an extremely efficient
pathway when compared to Rad51-mediated recombination
[14,15].
As a proof-of-concept for the SeeSaw reporters, we next
analyzed the impact of blocking established NHEJ and resection
factors in repair balance. [6]. The extent of mRNA depletion
obtained by shRNAs used in this work is shown in Figure 3. To
facilitate comparison between different reporters and experiments,
we normalized the HR/NHEJ ratio to the scramble control, and
plotted the fold increase values side-by-side (see Methods for
details; Figure 4). Any values greater than 1 represent a preference
for homology-independent repair; values less than 1 mean a bias
towards homology-dependent repair.
Hindering NHEJ Drives Cells to Repair Via a Homology-
driven Repair
It has been previously reported that impairing NHEJ drives cells
to increase DNA-end resection and homologous recombination in
several organisms [5,16–20]. Thus, we downregulated several key
players of NHEJ, namely, the three subunits of the DNA-PK
complex (DNA-PKcs, Ku70, and Ku80) and ligase 4 (Lig4). As
expected, we observed a deviation of the balance towards an
increase of homology-mediated repair (Figure 4, Tables S2 and
S3). These results agree with previously published reports that
indicate that, in the absence of NHEJ, DNA-end are unprotected,
resection occurs, and the breaks are more prone to be repaired by
homologous recombination [5,16–21]. Although we observed a
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similar trend for both SSR 1.0 and 2.0, it was clearer in the latter
(Figure 4). We believe this is due to the fact that accurate NHEJ in
the SSR 1.0 system renders a functional I-SceI target site that can
be recleaved. Thus, since only one cycle of break-repair takes place
for SSR 2.0, the full extent of the role of NHEJ, including accurate
and mutagenic, is discernable, whereas error-free repair renders a
re-cleavable target site and favors mutagenic repair for SSR 1.0,
making the picture less clear.
DNA end Resection Controls the Balance between
Homology-dependent and -Independent Repair
DNA end resection is the main process controlling the choice
between DSB repair pathways by licensing HR and inhibiting
NHEJ [4,5,9]. To validate our reporters, we analyzed the effect of
hindering resection by protein depletion (Figure 4, Tables S4 and
S5). shRNA-mediated depletion of cells for CtIP, BLM, or Exo1
strongly skewed our reporter towards NHEJ rather than HR, as
Figure 2. Initial characterization of the SSR systems. (A) Flow cytometer analysis of U2OS osteosarcoma cells transfected or not with control
vectors, pEGFP and pHc-RFP, or the SSR 1.0 system. For quantification, two regions (R1 and R2) were established following the comparison of U2OS
cells and cells transfected with control plasmids. R1 encompasses cells that fluoresce red above background levels, whereas R2 encompasses cells
that fluoresce green above background levels. (B) Cells stably expressing the SSR 1.0 and an shRNA against a scrambled sequence were transfected or
not with the I-SceI–BFP construct and analyzed for the presence of blue fluorescence. A gated region (gate1) was created to separate cells that
expressed the BFP protein. (C) Cells from Figure 1D that fell into the gate1 region were analyzed for red or green fluorescence, using R1 and R2 as
defined in Figure 2A. (D) Quantification by flow cytometry of the percentage of cells expressing GFP or RFP after I-SceI–BFP lentiviral infection in cells
harboring the SSR 1.0 or SSR 2.0 systems and a scrambled shRNA. Percentages were calculated as R1 (black, HR) or R2 (white, NHEJ) versus cells that
expressed any fluorescence (R1+R2). Data represent a minimum of three sets of duplicated experiments. Average percentage and standard error of
HR events is shown. (E) A sample image under a fluorescent microscope of cells harboring the SSR 1.0 system of cells that were repaired by NHEJ
(green) or HR (red). (F) PCR analysis of the cleavage efficiency and repair by NHEJ in the SSR 2.0 system. PCR products were obtained with
oligonucleotides located at the end of the GFP gene and the beginning of the FP fragment (see Figure 1B). Cleavage with I-SceI impaired the PCR
reaction, resulting in a reduction of the uncut fragment (see also Figure 1). Upon NHEJ repair, a new, faster migrating species appeared (cut-and-
repaired fragment; see Figure 1B). A PCR product of the actin gene using the same genomic DNA was used as loading control.
doi:10.1371/journal.pone.0077206.g002
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compared to control cells with a scrambled shRNA sequence.
When we compared the HR/NHEJ ratio, normalized to that from
the scrambled shRNA control, depletion of CtIP, BLM and Exo1
altered the ratio towards an increase in NHEJ (Figure 4).
Therefore, this reporter responded strongly to both short-range
and long-range DNA end resection. Mre11 has an essential role in
short-range resection but has also been implicated in other
processes, such as NHEJ, tethering both sides of the break, and
DSB sensing and checkpoint activation [22]. Thus, the outcome of
Mre11 depletion on DSB repair pathway choice is difficult to
predict and highly complex, since it would negatively affect both
NHEJ and HR. This is the type of question our reporters were
specifically designed to answer. When we depleted Mre11 in our
cells, we observed a deviation of the balance towards NHEJ,
demonstrating that Mre11 strongly favors homology-driven repair.
(Figure 4). This effect is likely due to the role Mre11 plays in DNA
end resection [22].
Thus, we confirmed that hindering DNA end resection clearly
skews the balance towards NHEJ. Similar effects were observed
after impairment of short-end and long-end resection (Figure 4).
Importantly, although we did not observe qualitative differences
between SSR 1.0 and SSR 2.0, we clearly distinguished
quantitative differences.
Figure 3. Reduction of the RNA levels upon shRNA-mediated depletion against several target genes. Quantitative RT-PCR data was
measured for mRNA in cells stably transfected with the indicated shRNAs. The mRNA level of each gene was normalized to actin mRNA. The mRNA
level of each gene in each cell line (black bars) was normalized to the levels in a cell line stably transfected with an shRNA with a scrambled sequence
(white bars). Average and s.e.m. of a minimum of three experiments with triplicates is plotted.
doi:10.1371/journal.pone.0077206.g003
Figure 4. Sensitivity of SSR systems to NHEJ and DNA send resection impairment. Effects of shRNA-mediated depletion of core NHEJ or
DNA end resection factors for the SSR 1.0 (A) and SSR 2.0 (B). To calculate the deviation from the balance between homology-dependent versus
homology-independent repair, the ratio between green versus red cells in each conditions was calculated. To facilitate comparing experiments, this
ratio was normalized for each shRNA with a scrambled sequence shRNA as a control. Those shRNAs that skewed the balance towards an increase in
homology-independent repair have a fold-increase of over 1 (green bars), while those with an increase in HR have a fold-decrease of less than one
(red bars). Data represent a minimum of three sets of duplicated experiments.
doi:10.1371/journal.pone.0077206.g004
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To confirm that the data obtained so far reflect the role of DNA
end resection and NHEJ in DSB repair pathway choice, and that
they were not due to spurious effects, we performed a rigorous
series of controls. First, it has been demonstrated that the cell cycle
is the major regulator of the election between homology-
independent and homology-dependent repair [5,23–26]. Whereas
G1 cells can only use NHEJ, S and G2 cells can activate HR
through a CDK-mediated licensing of DNA end resection [5,23–
26]. We therefore analyzed cell cycle profiles of cells depleted for
all the factors used in this study; we observed no differences that
could explain the imbalance in repair pathway choice (Figure 5).
As an additional control, we decided to deplete a protein related to
Figure 5. Cell cycle distribution after shRNA-mediated depletion of several target genes. A representative FLOW cytometry plot after
downregulation of the indicated target genes with shRNA is shown.
doi:10.1371/journal.pone.0077206.g005
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DSB repair that should have no effect on repair pathway choice,
namely, Rad51. Rad51 is involved in late steps of homologous
recombination, following the decision for HR or NHEJ [4,9,15].
More importantly, Rad51 is not involved in SSA [4,9,15], hence
avoiding indirect effects due to the repair mechanism itself rather
than pathway choice. Indeed, depletion of Rad51 had no effect on
the SeeSaw reporters (Figure 4).
The DNA Damage Response and the Regulation of DSB
Repair Pathway Choice
The cellular context determines which is the best way to repair a
DNA break. The coordination between DNA repair and cellular
metabolism relies on a complex signal transduction cascade known
as DNA damage response (DDR) [1,2]. We decided to investigate
the role of different DDR factors on influencing the balance
between HR and NHEJ.
DDR is initiated by a series of protein phosphorylation by two
kinases, ATM and ATR [1,2]. shRNA-mediated depletion of
either ATM or ATR resulted in a pronounced swing of the
homology-mediated versus -independent repair balance, towards
the latter (Figure 6). These results agree with a role of both ATM
and ATR in favoring DNA end resection. DDR-mediated
phosphorylation triggers the recruitment of multiple proteins to
the vicinity of the breaks, including the E3-ubiquitin ligases RNF8,
RNF168 and BRCA1. The activities of all three of these ligases are
essential for DDR and DNA repair. Here, we showed that
downregulation of RNF8, RNF168, or BRCA1 also skewed the
balance towards NHEJ (Figure 6). This effect was specific for DNA
damage–dependent ubiquitination, as similar (but more pro-
nounced) results were obtained upon downregulation of the DNA
damage–related E2 ubiquitin ligase UBC13 [27] (Figure 6), but
general impairment of protein ubiquitination with the proteasome
inhibitor MG132, which causes ubiquitin depletion, did not
significantly alter the HR/NHEJ balance (Figure 6). Additionally,
sumoylation takes place at the sites of breaks due to the activity of
the E2-sumo ligase UBC9 and the E3-sumo ligases PIAS1 and
PIAS4 [28]. shRNA-mediated depletion of any of these also
imbalanced the HR/NHEJ ratio towards NHEJ (Figure 6).
Therefore, we conclude that DDR-mediated phosphorylation,
ubiquitylation, and sumoylation are involved in the DSB pathway
choice and are required for HR.
Conclusions
In summary, we have designed specific reporters to study the
balance between homology-directed and homology-independent
repair of DSBs. These systems can be used to analyze in an
unbiased way the effect of any factor on this repair pathway
choice. This will allow us to isolate and characterize new factors
involved in this regulation. For our reporters, it is irrelevant if a
factor has an increased or reduced ability to perform either HR or
NHEJ or both, since we instead study its role in maintaining the
balance. Our systems could be applied to understand one specific
factor or an entire pathway, or to genome-wide screenings and
drug discovery. Moreover, our findings can be applied to increase
gene-targeting efficiency, a beneficial tool for a broad audience in
the biological sciences.
Supporting Information
Figure S1 Single-integration clones of the HRNH1.0
reporter. A, Southern blot analysis of HRNH1.0 integration in
selected clones. Red arrows show clones harboring a single copy of
the reporter. B, Flow cytometer analysis of single copy clones to
determine the basal expression of GFP and RFP fluorescence
depending of the integration site.
(TIF)
Figure 6. DDR defects lead to an imbalance of the HR/NHEJ ratio. The HR and NHEJ balance in the SSR 1.0 (A) and SSR 2.0 (B) in cells depleted
of the checkpoint factors ATM, ATR, BRCA1, RNF169, RNF8, UBC13, UBC9, PIAS1, or PIAS4, or after MG-132 inhibition of proteasome activity. The
details are as given in Figure 4, except that data for the MG-132 results were normalized to cells treated with DMSO as a control.
doi:10.1371/journal.pone.0077206.g006
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from the BFP-positive pool in the SSR 2.0 system upon
shRNA-mediated downregulation of NHEJ factors.
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Table S4 Percentage of GFP and RFP expressing-cells
from the BFP-positive pool in the SSR 1.0 system upon
shRNA-mediated downregulation of DNA resection.
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Table S5 Percentage of GFP and RFP expressing-cells
from the BFP-positive pool in the SSR 2.0 system upon
shRNA-mediated downregulation of DNA resection.
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Table S6 Percentage of GFP and RFP expressing-cells
from the BFP-positive pool in the SSR 1.0 system upon
shRNA-mediated downregulation of the DNA damage
response.
(DOCX)
Table S7 Percentage of GFP and RFP expressing-cells
from the BFP-positive pool in the SSR 2.0 system upon
shRNA-mediated downregulation of the DNA damage
response.
(DOCX)
Acknowledgments
We want to thank Mike Certo and Andrew Scharenberg (University of
Washington, Seattle, Washington, USA) for technical advice and the gift of
the BFP-I-SceI construct, Marı´a Jose´ Quintero for technical help, Felix
Prado and Felipe Cortes-Ledesma for critical reading of the manuscript
and Veronica Raker for style corrections.
Author Contributions
Conceived and designed the experiments: PH. Performed the experiments:
DGC SJ MJFA. Analyzed the data: DGC SJ MJFA PH. Contributed
reagents/materials/analysis tools: DGC SJ. Wrote the paper: PH.
References
1. Ciccia A, Elledge SJ (2010) The DNA damage response: making it safe to play
with knives. Mol Cell 40: 179–204.
2. Jackson SP, Bartek J (2009) The DNA-damage response in human biology and
disease. Nature 461: 1071–1078.
3. Aguilera A, Gomez-Gonzalez B (2008) Genome instability: a mechanistic view of
its causes and consequences. Nat Rev Genet 9: 204–217.
4. Hartlerode AJ, Scully R (2009) Mechanisms of double-strand break repair in
somatic mammalian cells. Biochem J 423: 157–168.
5. Huertas P (2010) DNA resection in eukaryotes: deciding how to fix the break.
Nat Struct Mol Biol 17: 11–16.
6. Lieber MR (2008) The mechanism of human nonhomologous DNA end joining.
J Biol Chem 283: 1–5.
7. O’Driscoll M, Jeggo PA (2006) The role of double-strand break repair - insights
from human genetics. Nat Rev Genet 7: 45–54.
8. San Filippo J, Sung P, Klein H (2008) Mechanism of eukaryotic homologous
recombination. Annu Rev Biochem 77: 229–257.
9. Heyer WD, Ehmsen KT, Liu J (2010) Regulation of homologous recombination
in eukaryotes. Annu Rev Genet 44: 113–139.
10. McVey M, Lee SE (2008) MMEJ repair of double-strand breaks (director’s cut):
deleted sequences and alternative endings. Trends Genet 24: 529–538.
11. Wang H, Rosidi B, Perrault R, Wang M, Zhang L, et al. (2005) DNA ligase III
as a candidate component of backup pathways of nonhomologous end joining.
Cancer Res 65: 4020–4030.
12. Dynan WS, Yoo S (1998) Interaction of Ku protein and DNA-dependent
protein kinase catalytic subunit with nucleic acids. Nucleic Acids Res 26: 1551–
1559.
13. Cao L, Xu X, Bunting SF, Liu J, Wang RH, et al. (2009) A selective requirement
for 53BP1 in the biological response to genomic instability induced by Brca1
deficiency. Mol Cell 35: 534–541.
14. Fishman-Lobell J, Rudin N, Haber JE (1992) Two alternative pathways of
double-strand break repair that are kinetically separable and independently
modulated. Mol Cell Biol 12: 1292–1303.
15. Paques F, Haber JE (1999) Multiple pathways of recombination induced by
double-strand breaks in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 63: 349–
404.
16. Chapman JR, Barral P, Vannier JB, Borel V, Steger M, et al. (2013) RIF1 is
essential for 53BP1-dependent nonhomologous end joining and suppression of
DNA double-strand break resection. Mol Cell 49: 858–871.
17. Clerici M, Mantiero D, Guerini I, Lucchini G, Longhese MP (2008) The Yku70-
Yku80 complex contributes to regulate double-strand break processing and
checkpoint activation during the cell cycle. EMBO Rep 9: 810–818.
18. Escribano-Diaz C, Orthwein A, Fradet-Turcotte A, Xing M, Young JT, et al.
(2013) A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and
BRCA1-CtIP controls DNA repair pathway choice. Mol Cell 49: 872–883.
19. Zhang Y, Hefferin ML, Chen L, Shim EY, Tseng HM, et al. (2007) Role of
Dnl4-Lif1 in nonhomologous end-joining repair complex assembly and
suppression of homologous recombination. Nat Struct Mol Biol 14: 639–646.
20. Zierhut C, Diffley JF (2008) Break dosage, cell cycle stage and DNA replication
influence DNA double strand break response. EMBO J 27: 1875–1885.
21. Munoz-Galvan S, Lopez-Saavedra A, Jackson SP, Huertas P, Cortes-Ledesma
F, et al. (2013) Competing roles of DNA end resection and non-homologous end
joining functions in the repair of replication-born double-strand breaks by sister-
chromatid recombination. Nucleic Acids Res 41: 1669–1683.
22. Stracker TH, Petrini JH (2011) The MRE11 complex: starting from the ends.
Nat Rev Mol Cell Biol 12: 90–103.
23. Aylon Y, Kupiec M (2004) New insights into the mechanism of homologous
recombination in yeast. Mutat Res 566: 231–248.
24. Huertas P, Cortes-Ledesma F, Sartori AA, Aguilera A, Jackson SP (2008) CDK
targets Sae2 to control DNA-end resection and homologous recombination.
Nature 455: 689–692.
25. Huertas P, Jackson SP (2009) Human CtIP mediates cell cycle control of DNA
end resection and double strand break repair. J Biol Chem 284: 9558–9565.
26. Ira G, Pellicioli A, Balijja A, Wang X, Fiorani S, et al. (2004) DNA end
resection, homologous recombination and DNA damage checkpoint activation
require CDK1. Nature 431: 1011–1017.
27. Zhao GY, Sonoda E, Barber LJ, Oka H, Murakawa Y, et al. (2007) A critical
role for the ubiquitin-conjugating enzyme Ubc13 in initiating homologous
recombination. Mol Cell 25: 663–675.
28. Galanty Y, Belotserkovskaya R, Coates J, Polo S, Miller KM, et al. (2009)
Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA
double-strand breaks. Nature 462: 935–939.
Double Strand Break Repair Balance
PLOS ONE | www.plosone.org 9 October 2013 | Volume 8 | Issue 10 | e77206
